LBC
LLY icon

Lowe Brockenbrough & Co’s Eli Lilly LLY Stock Holding History

Lowe Brockenbrough & Co’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.66M Sell
8,328
-141
-2% -$143K 0.38% 66
2025
Q4 		$9.1M Buy
8,469
+1,749
+26% +$1.67M 0.45% 61
2025
Q3 		$5.13M Sell
6,720
-65
-1% -$48.4K 0.26% 83
2025
Q2 		$5.29M Sell
6,785
-45
-0.7% -$35K 0.3% 80
2025
Q1 		$5.64M Sell
6,830
-121
-2% -$101K 0.37% 71
2024
Q4 		$5.37M Hold
6,951
– – 0.34% 73
2024
Q3 		$6.16M Buy
6,951
+121
+2% +$109K 0.39% 68
2024
Q2 		$6.18M Sell
6,830
-315
-4% -$252K 0.41% 68
2024
Q1 		$5.56M Buy
7,145
+407
+6% +$290K 0.38% 75
2023
Q4 		$3.93M Sell
6,738
-48
-0.7% -$28K 0.3% 86
2023
Q3 		$3.64M Sell
6,786
-250
-4% -$129K 0.28% 94
2023
Q2 		$3.3M Sell
7,036
-142
-2% -$59.6K 0.25% 95
2023
Q1 		$2.47M Buy
7,178
+188
+3% +$63.4K 0.2% 110
2022
Q4 		$2.56M Sell
6,990
-200
-3% -$70.9K 0.22% 103
2022
Q3 		$2.33M Sell
7,190
-300
-4% -$95K 0.22% 104
2022
Q2 		$2.43M Sell
7,490
-168
-2% -$50.4K 0.21% 108
2022
Q1 		$2.19M Sell
7,658
-300
-4% -$77.2K 0.16% 127
2021
Q4 		$2.2M Hold
7,958
– – 0.16% 118
2021
Q3 		$1.84M Hold
7,958
– – 0.14% 137
2021
Q2 		$1.83M Hold
7,958
– – 0.16% 115
2021
Q1 		$1.49M Sell
7,958
-1,342
-14% -$263K 0.14% 128
2020
Q4 		$1.57M Sell
9,300
-120
-1% -$17.9K 0.17% 117
2020
Q3 		$1.39M Buy
9,420
+50
+0.5% +$7.74K 0.17% 118
2020
Q2 		$1.54M Sell
9,370
-50
-0.5% -$7.67K 0.21% 109
2020
Q1 		$1.31M Sell
9,420
-889
-9% -$122K 0.22% 106
2019
Q4 		$1.35M Buy
10,309
+14
+0.1% +$1.62K 0.17% 128
2019
Q3 		$1.15M Buy
10,295
+300
+3% +$33.4K 0.15% 132
2019
Q2 		$1.11M Hold
9,995
– – 0.15% 131
2019
Q1 		$1.3M Hold
9,995
– – 0.18% 122
2018
Q4 		$1.16M Sell
9,995
-500
-5% -$55.9K 0.19% 116
2018
Q3 		$1.13M Sell
10,495
-1,121
-10% -$112K 0.16% 127
2018
Q2 		$991K Hold
11,616
– – 0.15% 129
2018
Q1 		$899K Buy
11,616
+421
+4% +$33.9K 0.13% 135
2017
Q4 		$946K Hold
11,195
– – 0.14% 130
2017
Q3 		$958K Hold
11,195
– – 0.15% 127
2017
Q2 		$921K Sell
11,195
-112
-1% -$9.14K 0.14% 127
2017
Q1 		$951K Buy
11,307
+112
+1% +$8.97K 0.15% 120
2016
Q4 		$823K Hold
11,195
– – 0.14% 128
2016
Q3 		$899K Sell
11,195
-30
-0.3% -$2.4K 0.16% 121
2016
Q2 		$884K Sell
11,225
-65
-0.6% -$4.89K 0.15% 117
2016
Q1 		$813K Buy
11,290
+65
+0.6% +$4.92K 0.14% 124
2015
Q4 		$946K Sell
11,225
-2,360
-17% -$196K 0.16% 123
2015
Q3 		$1.14M Sell
13,585
-20
-0.1% -$1.69K 0.2% 109
2015
Q2 		$1.14M Sell
13,605
-30
-0.2% -$2.29K 0.18% 117
2015
Q1 		$991K Hold
13,635
– – 0.16% 128
2014
Q4 		$941K Hold
13,635
– – 0.15% 125
2014
Q3 		$884K Hold
13,635
– – 0.14% 125
2014
Q2 		$848K Sell
13,635
-150
-1% -$8.95K 0.14% 131
2014
Q1 		$811K Sell
13,785
-7,965
-37% -$445K 0.14% 129
2013
Q4 		$1.11M Hold
21,750
– – 0.18% 108
2013
Q3 		$1.09M Sell
21,750
-34,930
-62% -$1.83M 0.2% 105
2013
Q2 		$2.78M Buy
+56,680
New +$3.08M 0.52% 69

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Lowe Brockenbrough & Co's LLY Position: Q1 2026 in Review

Lowe Brockenbrough & Co reduced its Eli Lilly (LLY) stake by 1.7% in Q1 2026, selling an estimated $143K and leaving 8,328 shares worth $7.66M. The position accounts for 0.38% of the portfolio, ranked #66.

Lowe Brockenbrough & Co first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.1M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Lowe Brockenbrough & Co held 8,328 shares of Eli Lilly worth $7.66M as of Q1 2026.
  • Lowe Brockenbrough & Co sold 141 Eli Lilly shares in Q1 2026, an estimated $143K.
  • Eli Lilly made up 0.38% of Lowe Brockenbrough & Co's portfolio in Q1 2026, its #66 holding.
  • Lowe Brockenbrough & Co first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Lowe Brockenbrough & Co's Eli Lilly position peaked at $9.1M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Lowe Brockenbrough & Co's 13F filing for Q1 2026, filed 7 May 2026.